Corporate Information

Transgene Biotek Ltd Industry : (Healthcare)

BSE Code : 526139

NSE Symbol : -

P/E(TTM) : -

ISIN Demat : INE773D01018

Div & Yield% : -

EPS(TTM) : -

Book Value(₹) : -0.89

Market Cap(₹Cr) : 56.75

Face Value(₹) : 10.00

  Mar '24 Mar '23 Mar '22 Mar '21 Mar '20
SOURCES OF FUNDS :          
Equity Share Capital 75.77 75.77 75.77 75.77 75.77
Reserves -82.64 -81.98 -75.97 -71.11 -60.67
Equity Share Warrants 0.00 0.00 0.00 0.00 0.00
Equity Application Money 0.00 0.00 0.00 0.00 0.00
Total Shareholders Funds -6.87 -6.21 -0.20 4.66 15.10
Secured Loans 4.93 4.80 4.62 4.39 4.13
Unsecured Loans 9.07 8.32 7.40 6.94 6.20
Total Debt 14.00 13.12 12.02 11.33 10.33
Other Liabilities 23.20 23.37 23.55 23.72 23.90
Total Liabilities 30.33 30.28 35.37 39.71 49.33
APPLICATION OF FUNDS :          
Gross Block 107.61 107.61 107.61 107.61 107.58
Less: Accumulated Depreciation 101.25 101.16 96.21 86.28 76.38
Less:Impairment of Assets 0.00 0.00 0.00 0.00 0.00
Net Block 6.36 6.45 11.40 21.33 31.20
Lease Adjustments 0.00 0.00 0.00 0.00 0.00
Capital Work in Progress 1.87 1.87 1.87 1.87 1.87
Investments 0.10 0.11 0.11 0.01 0.00
Current Assets, Loans & Advances          
Inventories 0.03 0.03 0.09 0.02 0.04
Sundry Debtors 0.00 0.00 0.00 0.00 0.00
Cash and Bank Balance 0.01 0.00 0.02 0.01 0.04
Loans and Advances 1.06 1.00 0.58 0.60 0.60
Total Current Assets 1.10 1.04 0.69 0.64 0.67
Less : Current Liabilities and Provisions          
Current Liabilities 0.29 0.37 0.44 0.34 0.55
Provisions 1.83 1.82 1.41 6.93 6.99
Total CL & Provisions 2.11 2.19 1.85 7.28 7.54
Net Current Assets -1.01 -1.16 -1.16 -6.64 -6.87
Miscellaneous Expenses not written off 0.00 0.00 0.00 0.00 0.00
Deferred Tax Assets 0.00 0.00 0.00 0.00 0.00
Deferred Tax Liability 0.00 0.00 0.00 0.00 0.00
Net Deferred Tax 0.00 0.00 0.00 0.00 0.00
Other Assets 23.02 23.02 23.16 23.16 23.12
Total Assets 30.33 30.29 35.37 39.72 49.32
Contingent Liabilities 0.55 0.99 0.99 0.99 0.99